1alpha,3beta,4beta-p-Menthane-3,8-diol

Details

Top
Internal ID 247b3944-a79a-491a-bd92-5d50fbcbc0bf
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Menthane monoterpenoids
IUPAC Name (1R,2S,5S)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexan-1-ol
SMILES (Canonical) CC1CCC(C(C1)O)C(C)(C)O
SMILES (Isomeric) C[C@H]1CC[C@@H]([C@@H](C1)O)C(C)(C)O
InChI InChI=1S/C10H20O2/c1-7-4-5-8(9(11)6-7)10(2,3)12/h7-9,11-12H,4-6H2,1-3H3/t7-,8-,9+/m0/s1
InChI Key LMXFTMYMHGYJEI-XHNCKOQMSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H20O2
Molecular Weight 172.26 g/mol
Exact Mass 172.146329876 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 2.20
Atomic LogP (AlogP) 1.55
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
(1R,2S,5S)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexan-1-ol
(1R,2S,5S)-2-(1-hydroxy-1-methylethyl)-5-methylcyclohexanol
SCHEMBL14130644
CHEBI:48255
(+)-cis-p-Menthane-3,8-diol
(1S,3R,4S)-Menthan-3,8-diol
AKOS024319704
LMPR0102090050
Q27121110
(1S,2R,5R)-2-(1-Hydroxy-1-methylethyl)-5-methylcyclohexanol, AldrichCPR

2D Structure

Top
2D Structure of 1alpha,3beta,4beta-p-Menthane-3,8-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9823 98.23%
Caco-2 - 0.5392 53.92%
Blood Brain Barrier + 0.7750 77.50%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.6312 63.12%
OATP2B1 inhibitior - 0.8424 84.24%
OATP1B1 inhibitior + 0.9673 96.73%
OATP1B3 inhibitior + 0.9523 95.23%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior - 0.9431 94.31%
P-glycoprotein inhibitior - 0.9687 96.87%
P-glycoprotein substrate - 0.8765 87.65%
CYP3A4 substrate - 0.5852 58.52%
CYP2C9 substrate - 0.8012 80.12%
CYP2D6 substrate - 0.7198 71.98%
CYP3A4 inhibition - 0.8967 89.67%
CYP2C9 inhibition - 0.6604 66.04%
CYP2C19 inhibition - 0.8445 84.45%
CYP2D6 inhibition - 0.9401 94.01%
CYP1A2 inhibition - 0.6966 69.66%
CYP2C8 inhibition - 0.9570 95.70%
CYP inhibitory promiscuity - 0.9403 94.03%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.6846 68.46%
Eye corrosion - 0.8801 88.01%
Eye irritation + 0.9071 90.71%
Skin irritation + 0.6031 60.31%
Skin corrosion - 0.9128 91.28%
Ames mutagenesis - 0.8216 82.16%
Human Ether-a-go-go-Related Gene inhibition - 0.5923 59.23%
Micronuclear - 1.0000 100.00%
Hepatotoxicity + 0.7500 75.00%
skin sensitisation + 0.6602 66.02%
Respiratory toxicity - 0.7111 71.11%
Reproductive toxicity - 0.5222 52.22%
Mitochondrial toxicity - 0.6250 62.50%
Nephrotoxicity - 0.6920 69.20%
Acute Oral Toxicity (c) III 0.7766 77.66%
Estrogen receptor binding - 0.8679 86.79%
Androgen receptor binding - 0.8596 85.96%
Thyroid receptor binding - 0.6596 65.96%
Glucocorticoid receptor binding - 0.7897 78.97%
Aromatase binding - 0.8600 86.00%
PPAR gamma - 0.8814 88.14%
Honey bee toxicity - 0.9169 91.69%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity + 0.6200 62.00%
Fish aquatic toxicity + 0.8369 83.69%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.56% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.63% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.15% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.93% 91.11%
CHEMBL2581 P07339 Cathepsin D 82.30% 98.95%

Cross-Links

Top
PubChem 22214620
NPASS NPC215242